| scholarly article | Q13442814 |
| P2093 | author name string | Diego Sangiorgi | |
| Ezio Degli Esposti | |||
| Luca Degli Esposti | |||
| Stefano Buda | |||
| Francesco Scaglione | |||
| P2860 | cites work | Influence of sex on treatment and outcome in chronic heart failure. | Q37877792 |
| Sex-related differences in patients' responses to heart failure therapy | Q37983683 | ||
| Age-related medication adherence in patients with chronic heart failure: A systematic literature review | Q38385831 | ||
| Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario | Q39916558 | ||
| Non-adherence to antihypertensive medication: The role of mental and physical comorbidity. | Q40057462 | ||
| Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. | Q44022356 | ||
| Therapeutic equivalent substitute that is new or unfamiliar to the chronic patient may result in medication error. | Q44600104 | ||
| Polypharmacy and prescribing quality in older people | Q46248077 | ||
| Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients | Q47432715 | ||
| The substance of the brand | Q48631548 | ||
| Compliance with cardiovascular disease prevention strategies: a review of the research | Q74594262 | ||
| Generic substitution of antihypertensive drugs: does it affect adherence? | Q81517189 | ||
| Predictors of long-term persistence on statins in a subsidized clinical population | Q82494168 | ||
| Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice | Q83311084 | ||
| Generic and therapeutic statin switches and disruptions in therapy | Q83606497 | ||
| Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis | Q84339932 | ||
| Generic substitution: additional challenge for adherence in hypertensive patients? | Q84469787 | ||
| Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database | Q84520429 | ||
| A strategy to reduce cardiovascular disease by more than 80% | Q24679592 | ||
| The challenge of polypharmacy in cardiovascular medicine. | Q30381521 | ||
| Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of Italy. | Q30724115 | ||
| Interventions for helping patients to follow prescriptions for medications | Q30868125 | ||
| Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy | Q30978981 | ||
| Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy. | Q31053824 | ||
| Why do the same drugs look different? Pills, trade dress, and public health | Q34197967 | ||
| The effect of switching on compliance and persistence: the case of statin treatment. | Q34465099 | ||
| Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway | Q34494595 | ||
| Meta-analysis: impact of drug class on adherence to antihypertensives | Q34887070 | ||
| Overlapping medication associated with healthcare switching among Korean elderly diabetic patients. | Q35511553 | ||
| Generic substitution | Q35624570 | ||
| Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention | Q35826989 | ||
| Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland | Q35869235 | ||
| A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges? | Q35901619 | ||
| Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands. | Q35942147 | ||
| Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study | Q36264222 | ||
| Factors affecting therapeutic compliance: A review from the patient's perspective | Q36822915 | ||
| Clinical review: impact of statin substitution policies on patient outcomes | Q37384820 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | e012003 | |
| P577 | publication date | 2016-11-02 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study | |
| P478 | volume | 6 |
| Q59794225 | All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with tr |
| Q39427698 | Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment |
| Q37693752 | Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units |
Search more.